Enlivex Therapeutics .(US:ENLV) Benzinga·2025-11-24 14:47Market Overview - U.S. stocks experienced an upward trend, with the Nasdaq Composite increasing by over 350 points on Monday. The Dow rose by 0.16% to 46,318.84, the NASDAQ increased by 1.60% to 22,629.51, and the S&P 500 gained 0.83% to 6,658.09 [1] - Communication services sector saw a significant rise of 2.7% on Monday, while energy stocks fell by 0.9% [2][1] Company Earnings - CureVac N.V. reported third-quarter earnings of $1.41 per share, surpassing the analyst consensus estimate of a loss of $0.17 per share. The company also reported quarterly sales of $63.295 million, exceeding the analyst consensus estimate of $14.520 million [3] Commodity Prices - In commodity markets, oil prices increased by 0.1% to $58.07, while gold prices decreased by 0.1% to $4,078.40. Silver and copper also saw slight declines of 0.1% and 0.4%, trading at $49.875 and $4.9935 respectively [6] Stock Movements - Enlivex Therapeutics Ltd. shares surged by 79% to $1.61 following a $212 million private placement announcement. Inspire Veterinary Partners, Inc. shares rose by 51% to $0.1836, while Inno Holdings Inc. shares increased by 44% to $1.04 due to a strategic cooperation announcement [10] - Conversely, Clearside Biomedical, Inc. shares plummeted by 67% to $0.8799 after filing for bankruptcy. Twin Hospitality Group Inc. shares fell by 28% to $2.5700, and ProMIS Neurosciences, Inc. shares dropped by 25% to $0.3157 following a reverse stock split announcement [10]